Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sectra publishes Annual Report and Sustainability Report for 2020/2021

Linköping – July 1, 2021 – Medical imaging IT and cybersecurity company Sectra  (STO: SECT B) publishes its Annual Report and Sustainability Report for the 2020/2021 fiscal year today. This report also includes the Corporate Governance Report for the same period.The document is attached to this press release and is available on Sectra’s website, investor.sectra.com. The website also provides a short overview of events and the company’s performance 2020/2021. The value we create for our various stakeholders, highlights from our operations, a selection of financial

Invitation to Mycronic’s Q2 2021 presentation

Analysts, investors and media are invited to the presentation of Mycronic’s Q2. The presentation will be held on July 15, at 10:00 a.m. The report is published on July 15, at 8:00 a.m. and will, together with the conference call slides, be available on www.mycronic.com. Anders Lindqvist, CEO and Torbjörn Wingårdh, CFO will present the company’s development. The presentation is held as an audio web cast and a telephone conference. After the presentation, which is held in English, a Q&A session will follow. Dial in details and audio web castIn order to participate by phone, dial one

Karo Pharma divests brand portfolio to Evolan Pharma

Karo Pharma AB (“Karo”) today announces the divestment of a portfolio consisting of 12 brands to Evolan Pharma AB (“Evolan”). The transaction is effective per today, July 1[st], 2021.Following the acquisitions of recent years, Karo has carried out a strategic evaluation of its products in order to streamline and optimize its commercial portfolio. As an outcome of that evaluation, 12 brands (Citodon, Morfin Special, Sincon, Bamse, Oliva, Karbasal, Complete, Nazamer, Ferromax, Tussin, Samin and Conotrane) have been identified, which are not in line with our growth strategy. Subsequently, Karo

Europi Property Group and Trinova launch £200m JV investing in prime offices in the UK’s ‘Big 6’ cities

Swedish real estate investor, Europi Property Group, together with Trinova Real Estate has launched a new joint venture, ‘Citybee’. Initially, Citybee will seek to invest £200m in grade A, prime office assets within the UK’s ‘Big 6’ regional urban centres (Bristol, Glasgow, Edinburgh, Manchester, Leeds, and Birmingham). The JV, over the last six months completed on four seed assets for the strategy in Leeds, Glasgow, Edinburgh & Manchester. Minerva House in Leeds is a 100% occupied, prime, grade-A office asset in the heart of the city. The Cuprum Building similarly, is a 100% occupied,

Targovax ASA appoints Dr Lone Ottesen as Chief Development Officer

Oslo, Norway, 1 July 2021 - Targovax ASA (OSE: TRVX) announces the appointment of Dr Lone Ottesen, MD, PhD as Chief Development Officer (CDO). She will take a leading role in driving the clinical programs forward. Dr Ottesen will serve as a member of Targovax’s management team.Dr Ottesen is a highly experienced drug developer with extensive experience across the global oncology and immune-oncology drug development spectrum with nearly 20 years in the pharmaceutical industry in both early- and late-phase development. Lone got her MD and PhD at Aarhus University in Denmark and has held roles

BioStock: Aptahem has identified a mechanism of action for Apta-1

Since 2019, Aptahem has collaborated with the Cardiovascular Research Centre (CVRC) at Örebro University to better understand certain mechanisms behind Apta-1's effect. Now the collaboration has borne fruit by identifying and clarifying a mechanism of action for the drug candidate Apta-1. BioStock contacted Luiza Jedlina, CSO at Aptahem, to find out more about what this means for Aptahem.Read the full article at biostock.se: https://www.biostock.se/en/aptahem-has-identified-a-mechanism-of-action-for-apta-1/This is a press release from BioStock - Connecting Innovation & Capital. https://

Nordic Capital raises over EUR 1.2 billion for its first mid-market Evolution Fund in a record three months

· Nordic Capital applies its winning sector model and powerful platform to a broader spectrum of mid-market companies across Northern Europe with its first Evolution Fund · Continued focus on successful partnerships with growth companies in Nordic Capital’s focus sectors to accelerate sustainable growth and expansionNordic Capital today announced the successful first and final close of its first Evolution Fund at just over EUR 1.2 billion (including GP commitment of 6.8%). Launched in April 2021 and raised in only three months, the Fund was substantially oversubscribed at its hard cap

RKW focuses on comprehensive sustainability

Mannheim/Germany, July 1, 2021 – The RKW Group has released its new Sustainability Report, which is aligned for the first time with the UN Sustainable Development Goals (SDGs).“We are committed to abiding by the SDGs as the building blocks of sustainable development. They also form the basis for all corporate activities in this vital area,” says Harald Biederbick, Chairman of the Executive Management Board at RKW SE. The RKW Sustainability Report 2020 summarizes the company’s strategy, goals, and results achieved to date. With its interactive format, it also represents a starting point for

Acquisition of 49.9% interest in one dual-fuel container vessel with 18-year charter

Ocean Yield ASA ("Ocean Yield") has agreed to acquire 49.9% equity interest in one dual-fuel newbuilding container vessel with 18-year bareboat charter to a major European container line. The vessel, with a capacity of 15,300 TEUs is under construction at Hyundai Heavy Industries in Korea and is expected to be delivered in Q3 2022. The vessel will be fitted with a dual-fuel engine and will be able to operate on LNG. The vessel will commence its 18- year bareboat charter to a major European container line upon delivery.  The investment will be made through Box Holdings Inc., a joint

EQT Private Equity to sell Fertin Pharma to Philip Morris International

· EQT Private Equity to sell Fertin Pharma, a leading specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International for a headline Enterprise Value of DKK 5.1 billion  · Fertin Pharma’s products enable people to live healthier lives – supporting millions of customers with reducing and quitting harmful cigarette smoking, and easier-to-consume oral care products, among other platforms   · Under EQT Private Equity’s ownership, Fertin Pharma has continued and strengthened its transformation

Agilyx Announces Major Operating Milestone

· Company reaches 16,000 commercial operating hours, marking 4,400 tons of plastic waste converted · As a pioneer in advanced recycling with the first ever commercial scale closed loop facility of its kind, Agilyx has diverted the equivalent weight of 20 Statues of Liberty from landfillTIGARD, Oregon, USA – July 1, 2021 – Agilyx Corporation (AGLX), a wholly owned subsidiary of Agilyx AS (Euronext Growth (Oslo): “AGLX”) and a pioneer in the chemical recycling of post-use plastics, announced that it has surpassed 16,000 hours of commercial operations at its certified chemical recycling

Conference call in connection with Collector’s interim report January-June 2021

Collector AB (publ) will publish the interim report for the period January-June 2021 on Thursday 15 July 2021 at 07:30 CET. A conference call will be held the same day starting at 10:30 CET, where CEO Martin Nossman and CFO Peter Olsson will present the report. The presentation will be held in Swedish and will be followed by a Q&A session.For those who wish to participate in the conference call, please dial +46 856 642 704 or +44 3333 009 260. It is also possible to follow and listen to the presentation live on https://tv.streamfabriken.com/collector-q2-2021.The presentation material will

Componenta Corporation has appointed Hanna Seppänen as General Counsel and a member of Corporate Executive Team

Componenta Corporation, Press release, 1 July 2021 at 11.00 a.m. EESTHanna Seppänen has been appointed as General Counsel and a member of Corporate Executive Team of Componenta Corporation Hanna Seppänen LL.M., 47, has been appointed as General Counsel and a member of Corporate Executive Team of Componenta Corporation as her predecessor has joined another employer. She shall take up her position on 1 November 2021. Most recently, Hanna Seppänen has served as Director, Legal and Investor relations in Siili Solutions Oyj. Previously she has served at Terveystalo as General Counsel and as a

EIRGRID PARTNERS WITH SMART WIRES ON GROUNDBREAKING GRID PROJECT

EirGrid is partnering with power technology firm Smart Wire Grid Europe (‘Smart Wires’), and the research and development consortium Electric Power Research Institute (EPRI) on a groundbreaking project aimed at boosting the flow of renewable energy on the electricity grid. This project is being supported with a financial contribution from the Sustainable Energy Authority of Ireland (SEAI) under the SEAI National Energy Research, Development & Demonstration Funding Programme 2019. The project is led by Ireland-based Smart Wires Europe with collaborators EirGrid and EPRI.This two-year project,

Study Reveals: No Pandemic-Driven Slowdown in MedTech, Yet Sustainable Growth Strategies Needed

The medtech industry is facing less price pressure and developed a better understanding of pricing as growth leverage. But digitalization remains a key issue to ensure sustainable profits.July 1, 2021 – The Global Pricing Study 2021 – Special Focus: MedTech* conducted by the global strategy and marketing consultancy Simon-Kucher & Partners  indicates: more than 60 percent of medtech companies globally improved their profit margins in 2020. However, with half of these improvements attributed to COVID-19 impacts, 64 percent of companies predict these are only

Swap agreement with Federal Reserve extended

The Riksbank has decided to extend the temporary swap agreement for up to USD 60 billion with the Federal Reserve Bank of New York. The extended agreement applies up to and including 31 December 2021.The swap agreement with the Federal Reserve was first concluded in March 2020 and is now being extended for a third time. The current agreement runs up to and including 30 September 2021 but is being extended up to and including 31 December 2021. The agreement is part of a wider arrangement between the Fed and a number of other central banks around the world aimed at improving liquidity

CEO of Risk Intelligence purchases 90,000 shares

On the 1 July the CEO of Risk Intelligence (RISK.SS), Hans Tino Hansen announced a purchase of 90,000 shares (83,342 warrants executed at DKK 3.00 and 6,658 shares acquired in the market at value weighted average price of DKK 5.20) equal to a total amount of DKK 289,904.Risk Intelligence CEO Hans Tino Hansen says:As an insider I only have certain windows of opportunity when to conduct trade in the Risk Intelligence share. I have taken this opportunity to further invest in the future growth of Risk Intelligence. Hans Tino Hansen’s total shareholdings after this transaction are 3,100,000

Acquisition between Valio and Heinon Tukku is approved

On 30.6.2021 the Finnish Competition and Consumer Authority (FCCA) approved the transaction in which Valio Oy is acquiring Heinon Tukku Oy. With the transaction, Valio becomes an even more comprehensive partner for food industry professionals.“We are really pleased with the FCCA’s decision. Going forward, we will be a more comprehensive partner to those food industry professionals for whom quality, a deep understanding of customer needs, and delivery reliability are key factors. Heinon Tukku is a traditional family-owned company, and Valio is owned by Finnish dairy farmers. We share a

Monetary policy decision: Zero interest rate and asset purchases for inflation to be more permanently close to 2 per cent

The spread of infection of the coronavirus has declined and the economic outlook is brighter. However the pandemic is not yet over, and inflationary pressures are still moderate. By conducting an expansionary monetary policy, the Riksbank contributes to continued good development of the economy and to inflation attaining the target more permanently. The Executive Board has therefore decided to hold the repo rate unchanged at zero per cent and that during the fourth quarter the Riksbank will continue purchasing assets within the envelope of SEK 700 billion.Rising optimism, but great

Invitation to the presentation of Axfood’s second quarter 2021

Axfood invites investors, analysts and the press to a presentation of the interim report for the second quarter 2021 at 9:30 am CET on 15 July. The report will be published at 7:00 am CET the same day.Axfood’s President and CEO Klas Balkow will present the report together with CFO Anders Lexmon. The presentation will be held in English.Time: Thursday, 15 July at 9:30 am CETTo participate, please dial in:Sweden: +46 8 519 993 83The UK: +44 333 300 9268The US: +1 833 823 0586The presentation can also be followed live via webcast at axfood.com .

BioStock: Saniona’s CMO on the new clinical trial with SAN711

Saniona has generated promising preclinical data with SAN711 in multiple models of pain and rare neuropathic disorders. BioStock reached out to Rudolf Baumgartner, MD, Chief Medical Officer and Head of Clinical Development at Saniona, to learn more about the newly-initiated phase I safety study in healthy volunteers.Read the full article at biostock.se: https://www.biostock.se/en/sanionas-cmo-on-the-new-clinical-trial-with-san711/This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se

Cyxone and Medical University of Vienna announce collaboration to study broader T20K use in MS

After identifying some valuable new potential treatments for T20K, Cyxone AB (publ) (“Cyxone or the Company”) today announced that the company has entered into a research collaboration with Prof. Christian Gruber, the inventor of T20K & Prof. Gernot Schabbauer from the Medical University of Vienna. The aim of the study is to deepen the understanding of the mode of action (MoA) of T20K and to explore these new uses and the potential to provide significant additional therapeutic benefit in a model for multiple sclerosis. The study will start later this month, with planned readout in June 2022,

Utsikt Bredband choose Waystream

Utsikt Bredband AB places order worth millions Swedish crowns for a three-digit number of switches for its business. The products include units from 1 to 10 Gbits/s and enables Utsikt to offer super fast and stable broadband to its end customers.Press release July 1, 2021 Utsikt Bredband, part of Tekniska verken in Linköping AB, operates and develops an open, neutral city network for more than 65,000 households and companies in the municipalities of Linköping, Mjölby, Katrineholm, and parts of Motala municipality. Utsikt's ambitious vision is to build the world's most digitalised region

First transaction in the ECIT´s specialized 24SevenOffice technology unit

24SevenOffice partner ECIT AS has established a strategic business unit specialized on 24SevenOffice technology including AI accounting, and best practice. ECIT is an accounting and IT service provider with proforma 2020 revenue of NOK 2 billion and 2,100 employees across 9 countries. ECIT has now announced the first transaction in this partnership where the Norwegian 24SevenOffice tech savvy and AI enabled accounting firm, Value Group, is the first company to join ECIT´s business unit with focus on 24SevenOffice technology.  “It is great news that ECIT has closed the first accounting

There are no items matching the current filter
There are no more items matching the current filter
Back to top